glp-1 receptor agonist medicines How medications are transforming diabetes and weight loss treatment Study finds GLP-1 receptor agonists

Novo Nordisks WEGOVY (semaglutide) and Eli Lillys ZEPBOUND (tirzepatide) are reshaping the anti-obesity drug marketbut which powerhouse will claim the top spot in this high-stakes race

Westfall, E., Jeske, R

The leap from dual agonists like Tirzepatide to the potential triple action of Retatrutide signifies a monumental shift toward precision medicine in obesity treatment

When to seek immediate medical care for GLP-1 side effects Most GLP-1 side effects arent serious

J Neuroophthalmol 39(1):8293 De Simone R et al (2020) Headache in idiopathic intracranial hypertension A

Educated at Belfast Model School, Moore did evening courses at Belfast Working Men's Institute in order to get the necessary qualifications to study at Queen's College Belfast